Clinical Trials Browser

Phase 3 × Brain Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00096265 2018-03-09

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Phase 3 Terminated

126 enrolled 14 charts

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung